Healthcare Trust Inc
For the period ended Dec 31, 2023. Filed Mar 15, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 15, 2024
NHPBP$25.44+0.0%Stored close · as of Oct 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets as of December 31, 202 and
(In thousands, except share and per share data)
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| ASSETS | ||
| Real estate investments, at cost: | ||
| Land | $207,987 | $206,454 |
| Buildings, fixtures and improvements | 2,120,352 | 2,089,133 |
| Acquired intangible assets | 293,295 | 292,034 |
| Total real estate investments, at cost | 2,621,634 | 2,587,621 |
| Less: accumulated depreciation and amortization | (681,977) | (609,324) |
| Total real estate investments, net | 1,939,657 | 1,978,297 |
| Cash and cash equivalents | 46,409 | 53,654 |
| Restricted cash | 44,907 | 22,884 |
| Derivative assets, at fair value | 28,370 | 40,647 |
| Straight-line rent receivable, net | 26,325 | 25,276 |
| Operating lease right-of-use assets | 7,713 | 7,814 |
| Prepaid expenses and other assets | 35,781 | 34,554 |
| Deferred costs | 15,997 | 17,223 |
| Total assets | $2,145,159 | $2,180,349 |
| LIABILITIES AND EQUITY | ||
| Mortgage notes payable, net | $808,995 | $578,700 |
| Credit facilities, net | 361,026 | 530,297 |
| Market lease intangible liabilities, net | 8,165 | 9,407 |
| Accounts payable and accrued expenses (including $295 and $47 due to related parties as of December 31, 2023 and 2022, respectively) | 48,356 | 45,247 |
| Operating lease liabilities | 8,038 | 8,087 |
| Deferred rent | 6,500 | 5,925 |
| Distributions payable | 3,496 | 3,496 |
| Total liabilities | 1,244,576 | 1,181,159 |
| Stockholders’ Equity | ||
| 7.375% Series A cumulative redeemable perpetual preferred stock, $0.01 par value, 4,740,000 authorized as of December 31, 2023 and 2022; 3,977,144 issued and outstanding as of December 31, 2023 and 2022 | 40 | 40 |
| 7.125% Series B cumulative redeemable perpetual preferred stock, $0.01 par value, 3,680,000 authorized; 3,630,000 issued and outstanding as of December 31, 2023 and 2022 | 36 | 36 |
| Common stock, $0.01 par value, 300,000,000 shares authorized, 111,545,018 shares and 105,080,531 shares issued and outstanding as of December 31, 2023 and 2022, respectively | 1,115 | 1,051 |
| Additional paid-in capital | 2,509,303 | 2,417,059 |
| Accumulated other comprehensive income (loss) | 23,464 | 36,910 |
| Distributions in excess of accumulated earnings | (1,639,804) | (1,462,457) |
| Total stockholders’ equity | 894,154 | 992,639 |
| Non-controlling interests | 6,429 | 6,551 |
| Total equity | 900,583 | 999,190 |
| Total liabilities and equity | $2,145,159 | $2,180,349 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.